Call for Contributions

Contribute to CAMDA! Academic researchers and industry practitioners share their lates research and experience in the analysis of complex data. Many novel algorithms have been introduced at CAMDA first. Presentations often show novel insights from unusual approaches and angles of attack. The set annual analysis challenges provide unique opportunities, focus, and inspiration.

CAMDA Challenges 2018

Submission

Please register an intention to submit (a 200-word abstract) your research in the ISMB submission system by 5 April. Please submit your research by 13 May, and clearly indicate the presenting author. Extended abstracts are limited to 3-5 pages.

Submission Options

  1. Full methods research papers can be submitted to the regular ISMB Proceedings Track by 29 Jan, specifying CAMDA as intended target audience.
  2. To present late breaking methods research or analyses of the CAMDA challenge data sets you need to register a 200-word abstract (ISMB submission system) as intention to submit by 13 April, specifying CAMDA as intended target audience. You then upload an Extended abstract by the CAMDA submission deadline 13 May. Extended abstracts should include preliminary key results and figures. Based on the extended abstract, the scientific committee selects teams to present their work at the CAMDA conference, where updated results need to be shown.
  3. Note that you need to upload any results for the special FDA meta-analysis paper by 15 April.
  4. Paper or abstract submissions that could not be accepted for a talk presentation can be shown as posters.
  5. Work can directly be submitted for poster presentation.

If you submit an extended abstract, you are invited to further update and revise your manuscript after the conference, with full research papers due in September. Full research papers are published subject to fast-track peer review in a special CAMDA proceedings issue of the fully indexed, open access Biology Direct journal.

ISMB requires poster submission fees for late / non-member submissions, so please consider submitting poster abstracts early. Please clearly indicate if you would like a submitted full paper or extended abstract to automatically be considered as a submission for poster presentation if we cannot offer a conference talk, which will count as an early submission.

Submission Requirements

  • All research submitted to CAMDA must be previously unpublished original work intended for publication, including procedures and results.
  • Challenge data set embargo: Any challenge data that is not already in the public domain remains exclusive for participants in the contest until conference presentation. This means that no publication of your results is allowed prior to the CAMDA conference. Once research has been accepted for publication at CAMDA, however, dissemination by pre-print servers is fine and encouraged.
  • Research introducing data sets outside the set CAMDA challenges need to put these data in the context of the challenges and make both raw and derived data publicly available if the submitted work is accepted.
  • Methods research needs to include at least two independent types of validation, such as a benchmark on simulated data with known truth, a benchmark on real-world data with built-in truths, or an application to real-world data with critical biological / medical interpretation.
  • Researchers introducing novel computational approaches must make their procedure available to others (e.g., source code or commercial demo), and a publication of source code is strongly encouraged.

Please talk to us if you have any questions regarding the Submission or individual challenges - see the CAMDA forums listed at the bottom of the pages About CAMDA.

PAST KEYNOTE SPEAKERS

Atul Butte, MD, PhD
Atul Butte, MD, PhD
Stanford University School of Medicine

Nikolaus Rajewsky, PhD
Nikolaus Rajewsky, PhD
Max-Delbrück-Center for Molecular Medicine

Terry Speed, PhD
Terry Speed, PhD
The Walter and Eliza Hall Institute of Medical Research

Sandrine Dupoit, PhD
Sandrine Dudoit, PhD
University of California, Berkeley

John Quackenbush, PhD
John Quackenbush, PhD
Harvard School of Public Health

Eran Segal, PhD
Eran Segal, PhD
Weizmann Institute of Science

John Storey, PhD
John Storey, PhD
Princeton University

Chris Sander, PhD
Chris Sander, PhD
Memorial Sloan Kettering Cancer Center

Temple F. Smith, PhD
Temple F. Smith, PhD
Boston University

Curtis Huttenhower, PhD
Curtis Huttenhower, PhD
Harvard School of Public Health

Christopher E. Mason, PhD
Christopher E. Mason, PhD
Weill Cornell Medicine

Mick Watson, PhD
Mick Watson, PhD
The Roslin Institute

Lodewyk Wessels, PhD
Lodewyk Wessels, PhD
Netherlands Cancer Institute

Cesare Furlanello, PhD
Cesare Furlanello, PhD
Fondazione Bruno Kessler

IMPORTANT DATES
Intention to Submit due5 April 2018
FDA meta-analysis opt in due15 April 2018
Extended Abstract Proposals due13 May 2018
Notification of Accepted Contributions20 May 2018
Early Registration Closes7 Jun 2018
CAMDA2018 Conference7-8 Jul 2018
ISMB 2018 Conference6–10 Jul 2018
Full Paper Submission 24 Sep 2018
Click to save the dates!
CAMDA PARTNERS

Agilent Technologies

F1000Research

Biology Direct

FDA

MetaSUB

ISMB 2018 MAIN EVENT
STAY CONNECTED